A Pilot Study to Investigate the Clinical Utility of the Peregrine Monte Carlo Dose Calculation System for Radiation Therapy Treatment Planning
The utility of PEREGRINE Monte Carlo calculations for radiation treatment planning in a
clinical setting will be assessed by comparing results with other fully three-dimensional
programs. ROB will investigate PEREGRINE for clinical use at NCI.
Patients with documented malignancy requiring standard radiotherapy OR patients with a
benign condition for whom radiotherapy is indicated.
Documented connective tissue disease or Ataxia Telangiectasia.
Cognitively impaired patients who cannot give informed consent.
Other medical conditions deemed by the PI to make the patient ineligible.
Patients requiring emergent radiotherapy.
Patients who are not able to undergo a CT scan.
Type of Study:
Endpoint Classification: Safety/Efficacy Study, Primary Purpose: Treatment
United States: Federal Government
- External Beam Radiotherapy
- 3-D Programming
|National Cancer Institute (NCI)||Bethesda, Maryland 20892|